EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Unraveling the neuroimmune mechanisms in cancer-induced bone pain: New horizons for therapeutic intervention of the two-phase paradigm

Changming Wang iD, Haiwang Ji, Hanwen Wang, Ziyun Chen, Lan Zhou, Yan Yang, Yucui Jiang, Guang Yu iD, Ling Jiang, Zongxiang Tang

Proceedings of the National Academy of Sciences · 26.08.2025 · 122 (34)

DOI: 10.1073/pnas.2503779122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 19.08.2025. Verfasst von Changming Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, Jiangsu, China. Hauptthemen laut MEDLINE: Cancer Pain, Bone Neoplasms, Neuroimmunomodulation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), development plan of traditional chinese medicine and technology in Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer-induced bone pain (CIBP) is a severely painful condition that profoundly impacts patients’ quality of life. However, the neuroimmune mechanisms underlying CIBP remain largely elusive. Substance P (SP), which is known to play a pivotal role in pain perception, became the focal point of our study. To this end, we adopted a comprehensive approach combining behavioral and physiological methods to investigate its role in neuroimmune interactions in CIBP. The results showed that SP released by dorsal root ganglion (DRG) neurons via exocytosis initiates CIBP, with its release peaking on the 14th day and correlating with pain behavior. Macrophages were found to infiltrate the DRGs and the sciatic nerves. Notably, in mice with CIBP, the population of macrophage type I was significantly augmented. Significantly, we found that the deletion of macrophages led to a notable alleviation of CIBP, while the blockade of the SP-neurokinin 1 receptor pathway effectively mitigated the infiltration of macrophages and alleviated CIBP. In the advanced phase, DRGs released C-C Motif Chemokine Ligand 3 and C-C Motif Chemokine Ligand 2 to recruit macrophages. A two-phase model for CIBP progression in mice was proposed, with SP-induced macrophage infiltration in the primary phase and chemokine-mediated macrophage recruitment in the advanced phase. Our investigation has unearthed a previously unrecognized mechanism governing the neuroimmune interaction in CIBP, which highlights a critical target for impeding the progression of this debilitating pain, potentially opening up broad avenues for the development of effective therapeutic interventions at different stages of CIBP with cancer development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer PainBone NeoplasmsNeuroimmunomodulationAnimalsGanglia, SpinalMiceMacrophagesSubstance PMice, Inbred C57BLMaleFemale

Stichwörter der Autor:innen

DRGSPcancer-induced bone painmacrophagerecruitment

Substanzen

Substance P

Autor:innen und Institutionen

  • School of Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, Jiangsu, China.
  • School of Traditional Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, China.
  • Jiangsu Cancer Hospital, Nanjing 210000, Jiangsu, China.

ORCID-Profile: Changming Wang, Guang Yu

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • development plan of traditional chinese medicine and technology in Jiangsu Province

Zitieren

APA

Wang, C., Ji, H., Wang, H., Chen, Z., Zhou, L., Yang, Y., Jiang, Y., Yu, G., Jiang, L., & Tang, Z. (2025). Unraveling the neuroimmune mechanisms in cancer-induced bone pain: New horizons for therapeutic intervention of the two-phase paradigm. Proceedings of the National Academy of Sciences, 122(34). https://doi.org/10.1073/pnas.2503779122

Vancouver

Wang C, Ji H, Wang H, Chen Z, Zhou L, Yang Y, et al. Unraveling the neuroimmune mechanisms in cancer-induced bone pain: New horizons for therapeutic intervention of the two-phase paradigm. Proceedings of the National Academy of Sciences. 2025;122(34). doi:10.1073/pnas.2503779122

BibTeX
@article{Wang2025,
  author = {Wang, Changming and Ji, Haiwang and Wang, Hanwen and Chen, Ziyun and Zhou, Lan and Yang, Yan and Jiang, Yucui and Yu, Guang and Jiang, Ling and Tang, Zongxiang},
  title = {Unraveling the neuroimmune mechanisms in cancer-induced bone pain: New horizons for therapeutic intervention of the two-phase paradigm},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  volume = {122},
  number = {34},
  doi = {10.1073/pnas.2503779122}
}
Kostenlos starten →